Article Publish Status: FREE
Abstract Title:

Oligosaccharides fromSlow the Progress of Aging Mice by Regulating the Key Microbiota-Metabolite Pairs.

Abstract Source:

Evid Based Complement Alternat Med. 2019 ;2019:9306834. Epub 2019 Dec 19. PMID: 31929824

Abstract Author(s):

Yang Xin, Chen Diling, Chen Tianlu, Zhao Jun, Tang Xiaocui, Guo Yinrui, Shuai Ou, Deng Tianming, Hu Guoyan

Article Affiliation:

Yang Xin


The gut microbiota is considered an important factor in the progression of Alzheimer's disease (AD). Active research on the association between the metabolome and the gut microbiome is ongoing and can provide a large amount of beneficial information about the interactions between the microbiome and the metabolome. Previous studies have shown that the oligosaccharides from(OMO) can delay the progress of AD in model animals by regulating the diversity of the gut microbiome and metabolic components, and the correlation between the gut microbiome and metabolic components still needs to be further verified. This study applied a new two-level strategy to investigate and ensure the accuracy and consistency of the results. This strategy can be used to determine the association between the gut microbiome and serum metabolome in APP/PS1 transgenic mice and C57BL/6J male mice. The"spp.-Cholesterol,""spp.-L-valine,""spp.-L-acetylcarnitine,""spp.-L-valine,""spp.-L-valine,"and"spp.-L-acetylcarnitine"associations among specific"microbiota-metabolite"pairs were further identified based on univariate and multivariate correlation analyses and functional analyses. The key relevant pairs were verified by an independent oligosaccharide intervention study, and the gut microbiome and serum metabolome of the OMO intervention group were similar to those of the normal group. The results indicate that OMO can significantly suppress Alzheimer's disease by regulating the key microbiota-metabolite pairs. Therefore, this two-level strategy is effective in identifying the principal correlations in large datasets obtained from combinations of multiomic studies and further enhancing our understanding of the correlation between the brain and gut in patients with AD.

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.